Day One Biopharm Is Maintained at Buy by Jones Trading

Dow JonesDec 18 01:28 · Ratings

Day One Biopharmaceutical Analyst Ratings

BenzingaDec 18 01:17 · Ratings

Day One Biopharmaceuticals (DAWN) Posts Stellar Q3 but With Extreme Concentration Risk

TipRanksDec 17 16:54

JonesTrading Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Cuts Target Price to $34

Futu NewsDec 17 05:31 · Ratings

CBTN Partners With Day One to Drive New Therapies for Pediatric Brain Tumors

PR NewswireDec 16 22:56

Piper Sandler Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $40

Futu NewsDec 6 00:35 · Ratings